Evaluation of Corneal Endothelium in Adolescents with Juvenile Glaucoma

Table 2

ECD and CCT in four groups treated with different classes of topical antiglaucoma medications (CAI: carbonic anhydrase inhibitors, PGA: prostaglandin analogs, BB: beta-blocker, and CAI-BB: carbonic anhydrase inhibitor/beta-blocker combination).

Antiglaucoma; drug	(eyes)	ECD; Q1; Me; Q3	CCT; Q1; Me; Q3
(1) CAI	18	2344; 2730; 3068	0.519; 0.556; 0.576
(2) PGA	22	2599; 2773.5; 2972	0.526; 0.558; 0.568
(3) BB	20	2331; 2539.5; 2782.5	0.493; 0.532; 0.578
(4) CAI-BB	6	2445; 2551; 3546	0.52; 0.544; 0.574

Kruskall-Wallis test.